ANTIHIDROTICS - etsinnän tulokset

instituto grifols s.a. - ihmisen normaali immunoglobuliini - mucocutaneous lymph node syndrome; guillain-barre syndrome; bone marrow transplantation; purpura, thrombocytopenic, idiopathic; immunologic deficiency syndromes - immunoseerumit ja immunoglobuliinit, - replacement therapy in adults, children and adolescents (0-18 years) in: , primary immunodeficiency syndromes with impaired antibody production;, hypogammaglobulinaemia and recurrent bacterial infections in patients with chronic lymphocytic luekaemia, in whom prophylactic antibiotics have failed;, hypogammaglobulinaemia and recurrent bacterial infections in plateau-phase-multiple-myeloma patients who failed to respond to pneumococcal immunisation;, hypogammaglobulinaemia in patients after allogenic haematopoietic-stem-cell transplantation (hsct);, congenital aids with recurrent bacterial infections. , immunomodulation in adults, children and adolescents (0-18 years) in: , primary immune thrombocytopenia (itp), in patients at high risk of bleeding or prior to surgery to correct the platelet count;, guillain barré syndrome;, kawasaki disease.

Euroopan unioni - suomi - EMA (European Medicines Agency)

tygacil

pfizer europe ma eeig - tigesykliini - bacterial infections; skin diseases, bacterial; soft tissue infections - systeemiset bakteerilääkkeet, - tygacil is indicated in adults and in children from the age of eight years for the treatment of the following infections: , complicated skin and soft tissue infections (cssti), excluding diabetic foot infections, complicated intra-abdominal infections (ciai) , tygacil should be used only in situations where other alternative antibiotics are not suitable. on otettava huomioon viralliset ohjeet antibioottien tarkoituksenmukaisesta käytöstä. tarkoituksenmukaisesta käytöstä.

Suomi - suomi - Fimea (Suomen lääkevirasto)

doxal 10 mg tabletti, päällystetty

orion corporation - doxepini hydrochloridum - tabletti, päällystetty - 10 mg - doksepiini